SCHEMBL7063697

SCHEMBL7063697

CC(C)(C)c1ccc(NC(=O)C(=Cc2ccc(C(=O)NC(O)CC(=O)O)cc2)c2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 5/20 0.55
GCGR P47871 3/20 0.47
ADCY6 O43306 1/20 0.47
ADCY3 O60266 1/20 0.47
ADCY9 O60503 1/20 0.47
ADCY5 O95622 1/20 0.47
ADCY8 P40145 1/20 0.47
ADCY7 P51828 1/20 0.47
ADCY2 Q08462 1/20 0.47
ADCY1 Q08828 1/20 0.47
ADCY4 Q8NFM4 1/20 0.47
GIPR P48546 2/20 0.46
NR1H4 Q96RI1 4/20 0.45
EPHX2 P34913 3/20 0.45
GLP1R P43220 1/20 0.45
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063690 0.84 GCGR (0.64) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL7063692 0.84 GCGR (0.64) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6918886 0.84 GCGR (0.64) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6918883 0.84 GCGR (0.64) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6917348 0.81 TRPV1 (0.47) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6916113 0.75 GCGR (0.49) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6918882 0.70 SUCNR1 (0.43) TRPV1GCGRALDH1A1CYP3A4
SCHEMBL9072927 0.67 PARP15 (0.44) NR1H4EPHX2ALDH1A1KDM4EMEN1
SCHEMBL4097353 0.67 GCGR (0.72) TRPV1GCGRADCY6ADCY3ADCY9
SCHEMBL6914028 0.67 NR1H4 (0.47) TRPV1GCGRADCY6ADCY3ADCY9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762318-B2 CARBOXYLIC ACID OR TETRAZOLE DERIVATIZED SECONDARY AMIDES; ORAL ADMINISTRATION NOVO NORDISK A/S (DK) 2004-07-13 US disclosed
US-20030236292-A1 Stimulant releasing glucose from liver cells; antidiabetic agents PFIZER INC 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236292-A1 Stimulant releasing glucose from liver cells; antidiabetic agents GPR119, GLP1R, GIPR TRPV1 1946/4885GCGR 4/4885ADCY6 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.